$ABBV

1 thesis
bullish 0%neutral 0%bearish 100%
Avg return (1w)
Win rate (1w)
(0 resolved)

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

$ABBVSEC Form 4bearish
Sold 32,710 @ $250.00 avg · $8,177,500 · 2026-08-14

Form 4: Donoghoe Nicholas sold ABBV

Donoghoe Nicholas (EVP, CHIEF BUS/STRAT OFFICER at AbbVie Inc.) reported an open-market sale of 32,710 shares of ABBV at an average $250.00, roughly $8,177,500, in a Form 4 filed 2026-08-18.

View filing on SEC.gov →

End of results.